Allosteric enzymes control the flux of biochemical reactions in metabolic pathways.
Their regulatory properties enable the generation of complex metabolic pathways.
The conversion of A to B is the committed step, meaning once A is converted to B, B is destined to become F.
Allosteric enzymes catalyze the committed step of metabolic pathways, while Michaelis-Menten enzymes facilitate the remaining steps.
Committed steps are irreversible under cellular conditions.
Feedback inhibition regulates the amount of F synthesized.
The pathway product F inhibits enzyme e1 by binding to a regulatory site distinct from the active site.
Regulation of metabolic pathways can be complex, with allosteric enzymes potentially inhibited or stimulated by multiple regulatory molecules.
The reaction velocity of allosteric enzymes exhibits a sigmoidal relationship with substrate concentration, unlike the hyperbolic relationship seen in Michaelis-Menten kinetics.
All allosteric enzymes display quaternary structure, featuring multiple active sites and regulatory sites.
The concerted model explains the kinetics of allosteric enzymes:
The enzyme exists in two quaternary structures: T (tense) and R (relaxed).
T and R are in equilibrium: T \rightleftharpoons R
The T state is less active but more stable.
The R state is enzymatically more active but less stable.
All active sites must be in the same state (either all T or all R).
Substrate binding to one active site traps other active sites in the R state.
This disruption of the T \rightleftharpoons R equilibrium by substrate binding favors further substrate binding which known as cooperativity.
Allosteric enzymes are more sensitive to changes in substrate concentration near their K_M values compared to Michaelis-Menten enzymes.
This heightened sensitivity is known as the threshold effect.
The sequential model proposes that subunits of allosteric enzymes undergo sequential changes in structure, in contrast to the concerted model where all subunits change simultaneously.
Allosteric regulators disrupt the R \rightleftharpoons T equilibrium upon binding to the enzyme.
Inhibitors stabilize the T state, while activators stabilize the R state.
Homotropic effect: Disruption of the T \rightleftharpoons R equilibrium by substrates.
Heterotropic effect: Disruption of the T \rightleftharpoons R equilibrium by regulators.
Phosphoribosylpyrophosphate synthetase (PRS) is an allosteric enzyme in the purine nucleotide synthesis pathway.
A mutation leading to the loss of regulatory control (while maintaining catalytic activity) causes overproduction of purine nucleotides, subsequently converted to urate.
Overproduction of urate results in gout.
What would be the effect of a mutation in an allosteric enzyme that resulted in a T/R ratio of 0?
PROBLEM: Examine the metabolic pathway shown below. Which of the enzymes shown as “e” with a numeric subscript is likely to be the allosteric enzyme that controls the synthesis of G?